SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001102624-14-001828
Filing Date
2014-11-07
Accepted
2014-11-07 11:50:53
Documents
12
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 BOSTON THERAPEUTICS, INC. boston10q.htm 10-Q 560418
2 EXHIBIT 10.1 ex10_1.htm EX-10.1 264960
3 EXHIBIT 31.1 ex31_1.htm EX-31.1 18397
4 EXHIBIT 31.2 ex31_2.htm EX-31.2 18993
5 EXHIBIT 32.1 ex32_1.htm EX-32.1 7860
6 EXHIBIT 32.2 ex32_2.htm EX-32.2 7375
  Complete submission text file 0001102624-14-001828.txt   2965784

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT bthe-20140930.xml EX-101.INS 291854
8 XBRL TAXONOMY EXTENSION SCHEMA bthe-20140930.xsd EX-101.SCH 26314
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bthe-20140930_cal.xml EX-101.CAL 31674
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bthe-20140930_def.xml EX-101.DEF 39724
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE bthe-20140930_lab.xml EX-101.LAB 196524
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bthe-20140930_pre.xml EX-101.PRE 130777
Mailing Address 33 SOUTH COMMERCIAL STREET MANCHESTER NH 03101
Business Address 33 SOUTH COMMERCIAL STREET MANCHESTER NH 03101 978-886-0421
Boston Therapeutics, Inc. (Filer) CIK: 0001473579 (see all company filings)

IRS No.: 270801073 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-54586 | Film No.: 141203446
SIC: 2834 Pharmaceutical Preparations